Cure8 research brief
This large, population-based study suggests people with Crohn's disease have modestly higher overall mortality than matched controls and higher deaths from specific causes (colorectal cancer, renal disease, non-Hodgkin lymphoma, sepsis). Understanding these risks can guide monitoring and research priorities.
Adults with Crohn's disease or ulcerative colitis, caregivers, gastroenterologists, and researchers studying IBD outcomes and cancer surveillance.
This population-based matched cohort study (1984–2019) examined all-cause and cause-specific mortality in Crohn's disease (CD) and ulcerative colitis (UC) across pre-biologic and biologic eras. The authors report that overall mortality was modestly higher in CD than in matched controls, while UC mortality was similar to controls.
In era-stratified analyses the excess mortality in CD was more apparent during the biologic era and with longer follow-up. The study identified higher cause-specific mortality in CD from colorectal cancer, renal disease, non-Hodgkin lymphoma, and sepsis; UC had higher mortality from colorectal cancer and cholangiocarcinoma.
The analysis used Cox models for all-cause mortality and competing-risk methods for cause-specific deaths, with 13,306 IBD patients matched 1:10 to controls. If you have Crohn's disease or care for someone who does, this study highlights continued excess mortality for some causes and the importance of disease monitoring and cancer surveillance.
It does not test or recommend specific treatments and should not be used as a basis for changing therapy without discussing with a clinician. For clinicians and researchers, the paper provides era-stratified population-level mortality estimates and cause-specific hazard ratios that may inform further investigation into drivers of excess mortality in CD.
Structured content depth: abstract — the brief is grounded in the article abstract and reported era-stratified analyses. The study is observational and reports associations, not causes; era definitions (pre-biologic vs biologic) are time-based and do not identify individual treatment exposures. Interpret findings alongside individual clinical circumstances.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: International Organization for the Study of IBD (IOIBD); Bingham Chair in Gastroenterology
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
People with celiac disease may have higher risks for several digestive cancers and for inflammatory bowel diseases (Crohn’s and UC) according to this large French cohort study. Knowing these associations can help...
This meta-analysis suggests people with IBD—especially those with Crohn’s disease—have a modestly increased risk of stroke. That makes cardiovascular risk assessment and prevention potentially more important for people...
PSC is rare in the general population but substantially more common in people with IBD, particularly ulcerative colitis, and it raises long-term hepatobiliary risks including cholangiocarcinoma—so knowing how often PSC...
